Dr. Kevin Saunders Leads Groundbreaking Research on Activating Key Immune Cells for HIV Vaccine Development


A study led by Dr. Kevin Saunders (SoM) and the Duke Human Vaccine Institute has achieved a pivotal advancement in the quest for an effective HIV vaccine. By activating specific immune cells in monkeys, they successfully generated antibodies similar to those crucial for safeguarding against HIV in humans. Dr. Saunders, who was the study's first author, highlights the significance of this milestone and brings hope for the eventual development of a protective HIV vaccine. Read more about the study and see the full article here.